Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Bellicum amends IPO

    Bellicum Pharmaceuticals Inc., Houston, Texas Business: Cancer Date announced: 2014-12-09 Type: IPO To be raised: Up to $106.3 million Shares: 6.3 million Price: $15-$17 Underwriters: Jefferies; Citigroup; Piper Jaffray…

    Published on 12/15/2014
  • CytoSorbents amends follow-on

    CytoSorbents Corp. (OTCQB:CTSOD), Monmouth Junction, N.J. Business: Infectious Date announced: 2014-12-08 Type: Follow-on To be raised: Up to $12.7 million Shares: 2 million Price prior: $5.88 Underwriters: Brean …

    Published on 12/15/2014
  • Juno Therapeutics amends IPO

    Juno Therapeutics Inc., Seattle, Wash. Business: Cancer Date announced: 2014-12-09 Type: IPO To be raised: Up to $166.5 million Shares: 9.3 million Price: $15-$18 Underwriters: Morgan Stanley; JPMorgan; Goldman Sachs; …

    Published on 12/15/2014
  • Zosano amends IPO

    Zosano Pharma Corp., Fremont, Calif. Business: Drug delivery Date announced: 2014-12-10 Type: IPO To be raised: Up to $76.8 million Shares: 6.4 million Price: $10-$12 Underwriters: Ladenburg Thalmann; Roth Capital …

    Published on 12/15/2014
  • Adagene completes venture financing

    Adagene Inc., Suzhou, China Business: Antibodies Date completed: 2014-12-08 Type: Venture financing Raised: $8 million Investors: Fidelity Biosciences; Fidelity Growth Partners Asia; WuXi Corporate Venture Fund

    Published on 12/15/2014
  • Agios completes follow-on

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. Business: Cancer, Endocrine/Metabolic Date completed: 2014-12-10 Type: Follow-on Raised: $220 million Shares: 2 million Price: $110.75 Shares after offering: 36…

    Published on 12/15/2014
  • Anergis completes venture financing

    Anergis S.A., Epalinges, Switzerland Business: Inflammation Date completed: 2014-12-03 Type: Venture financing Raised: CHF14.5 million ($14.8 million) Investors: Sunstone Capital; BioMedInvest; Renaissance PME; WJFS

    Published on 12/15/2014
  • Aspen Park Pharmaceuticals completes venture financing

    Aspen Park Pharmaceuticals Inc., New York, N.Y. Business: Genitourinary, Endocrine/Metabolic Date completed: 2014-12-10 Type: Venture financing Raised: Not disclosed Investor: Not disclosed Note: The amount raised is …

    Published on 12/15/2014
  • Can-Fite completes direct public offering

    Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF), Petah Tikva, Israel Business: Cancer, Infectious, Autoimmune Date completed: 2014-12-02 Type: Direct public offering Raised: $8 million Shares: 1.8 million Price: $4…

    Published on 12/15/2014
  • Champions Oncology completes private placement of convertible notes

    Champions Oncology Inc. (OTCBB:CSBR), Hackensack, N.J. Business: Cancer Date completed: 2014-12-05 Type: Private placement of convertible notes Raised: $2 million Shares outstanding prior: 66.9 million Investor: Company…

    Published on 12/15/2014
  • Congenica completes venture financing

    Congenica Ltd., Hinxton, U.K. Business: Diagnostic, Genomics Date completed: 2014-12-05 Type: Venture financing Raised: 1 million ($1.6 million) Investor: Cambridge Innovation Capital plc

    Published on 12/15/2014
  • EpiBone completes venture financing

    EpiBone Inc., New York, N.Y. Business: Gene/Cell therapy, Musculoskeletal Date completed: 2014-12-08 Type: Venture financing Raised: $250,000 Investor: NetScientific

    Published on 12/15/2014
  • Flexion Therapeutics completes follow-on

    Flexion Therapeutics Inc. (NASDAQ:FLXN), Burlington, Mass. Business: Musculoskeletal, Autoimmune Date completed: 2014-12-12 Type: Follow-on Raised: $85.7 million Shares: 5 million Price: $17 Shares after offering: 20.7 …

    Published on 12/15/2014
  • Genfit completes private placement

    Genfit S.A. (Euronext:GNFT), Loos, France Business: Endocrine/Metabolic, Cardiovascular, Diagnostic Date completed: 2014-12-10 Type: Private placement Raised: 21.2 million ($26 million) Shares: 588,433 Price: 35.95 …

    Published on 12/15/2014
  • IGI completes private placement of senior convertible notes

    IGI Laboratories Inc. (NYSE-M:IG), Buena, N.J. Business: Drug delivery Date completed: 2014-12-11 Type: Private placement of senior convertible notes Raised: $125 million Shares outstanding prior: 52.8 million Investor:…

    Published on 12/15/2014
  • Kane completes private placement of units

    Kane Biotech Inc. (TSX-V:KNE), Winnipeg, Manitoba Business: Drug delivery, Dermatology Date completed: 2014-12-09 Type: Private placement of units Raised: C$1.2 million ($1 million) Units: 23.5 million Price: C$0.05 (…

    Published on 12/15/2014
  • Kite Pharma completes follow-on

    Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Business: Cancer Date completed: 2014-12-10 Type: Follow-on Raised: $188.2 million Shares: 3.5 million Price: $54 Shares after offering: 41.8 million Underwriters: …

    Published on 12/15/2014
  • MEI Pharma completes follow-on

    MEI Pharma Inc. (NASDAQ:MEIP), San Diego, Calif. Business: Cancer Date completed: 2014-12-12 Type: Follow-on Raised: $40 million Shares: 10 million Price: $4 Shares after offering: 31.8 million Underwriters: BofA …

    Published on 12/15/2014
  • Midatech Pharma completes IPO

    Midatech Pharma plc (LSE:MTPH), Abingdon, U.K. Business: Endocrine/Metabolic, Cancer, Drug delivery Date completed: 2014-12-08 Type: IPO Raised: 32 million ($49.8 million) Shares: 12 million Price: 267p Shares after …

    Published on 12/15/2014
  • Northern Biologics completes venture financing

    Northern Biologics, Toronto, Ontario Business: Antibodies, Cancer Date completed: 2014-12-10 Type: Venture financing Raised: $10 million Investor: Versant Ventures Note: Versant said the offering closed earlier this …

    Published on 12/15/2014
  • Novacyt completes private placement

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2014-12-09 Type: Private placement Raised: 3.1 million ($3.8 million) Shares: 744,004 Price: Not disclosed Shares after…

    Published on 12/15/2014
  • Prenetics completes venture financing

    Prenetics Inc., Hong Kong, China Business: Diagnostic Date completed: 2014-12-03 Type: Venture financing Raised: $2.7 million Investors: Company management; and other investors

    Published on 12/15/2014
  • Prometic completes private placement

    ProMetic Life Sciences Inc. (TSX:PLI; OTCQX:PFSCF), Laval, Quebec Business: Cancer, Autoimmune, Dermatology Date completed: 2014-12-09 Type: Private placement Raised: C$25.1 million ($21.9 million) Shares: 13.2 million …

    Published on 12/15/2014
  • reViral completes venture financing

    reViral Ltd., Cardiff, U.K. Business: Infectious Date completed: 2014-12-01 Type: Venture financing Raised: Not disclosed Investors: Existing investors; new investors

    Published on 12/15/2014
  • Tute Genomics completes venture financing

    Tute Genomics Inc., Salt lake City, Utah Business: Genomics Date completed: 2014-12-04 Type: Venture financing Raised: $2.3 million Investors: Eurovestech; Peak Ventures; angel investors Note: The financing is a series …

    Published on 12/15/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993